FDA Play: Revolutionary Medical Device (OTC:IMGG)
StocksHaven Investments profiles a new and radical medical device from Imaging3 Inc. (OTC:IMGG) is ready to set the standard, and revolutionize the way we look at X-ray, MRI and CT scans. Imaging 3 is currently awaiting FDA approval on their DViS (Dominion Volumetric Imaging Scanner). Currently, medical imaging is met with challenges of long waits, lack of space, lack of mobility, and limited uses. However, for the first time ever, health-care workers will be able to instantly view 3D, high-resolution images of virtually any part of the human body. Thus, Imaging 3 looks to change all that. Saving time, saving lives and reducing costs. This technology will “set the standard for the next 10 years.” The following article was composed by StocksHaven Investments alongside Professor Philip Runfeldt, a Behavioral Analyst who has worked with Fortune 500 companies and major Universities throughout the Southeast.
About Imaging3 Inc.
Imaging3, Inc. (Imaging3) is a medical device manufacturer, distributor and third-party service provider. The company has developed a technology, known as Dominion, which utilizes photo-fluoroscopy to produce three dimensional (3D) medical diagnostic images in real time. Imaging3 is also a remanufacturer of C-arms. The Company offers new, demonstration, remanufactured, refurbished and pre-owned systems in all price ranges from every manufacturer, including OEC, General Electric (GE), ISI, Philips, Siemens, FluoroScan, XiScan and Ziehm. The Company supplies full-size, compact and mini C-arms.
The company was founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. According to the companies undisputed claims NO OTHER device provides 3D real time images. This means saving time and that accounts to saving lives. At a fraction of the cost for devices that do less it can be used in emergency rooms and urology procedures. Doctors want to see 3D images allowing for depth and direction perception whether performing diagnostic or interventional procedures. They now must utilize 2Dimaging that doesn’t allow for this.
The full special report on the company appears today at http://www.stockshaven.com/fda-play-revolutionary-medical-device-otcimgg/
Disclosure: Both, StocksHaven Investments and Professor Runfeldt have positions in IMGG
To feature your publicly traded company in StocksHaven.com Alerts or as a fully profiled company, email us at email@example.com or visit http://www.stockshaven.com/ir_contract/ for more info
About StocksHaven Investments
StocksHaven Investments can be found at StocksHaven.com. It is a company offering a news portal covering the world financial news and equities sector. It features its own blog, free level 2 quotes, two way linking capability, mass e-mail distribution alerts, stock research reports, conference calls, news feeds, mailing list, videos, press release capability, stock commentaries, company reviews and other unique content including expert stock analysis from Michael Vlaicu. The company also offers Investor Relations contracting services.
For more financial and investment news, visit www.StocksHaven.com
Certain sections of this report contain forward-looking statements that are based on our reporters’ expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements, which include but are not limited to projections of revenues, earnings, segment performance, cash flows, contract awards, FDA announcements, trial and drug approvals, and company stability. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors including but not limited to the status or outcome of legal and/or regulatory proceedings.
All forward-looking statements speak only as of the date of this report or, in the case of any document incorporated by reference, the date of that document. All subsequent written and oral forward-looking statements attributable to the company or any person acting on the company’s behalf are qualified by the cautionary statements in this section. StocksHaven.Com does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this report.
- Contact Information
- Michael Vlaicu
- Founder and Lead Investment Analyst
- StocksHaven Investments
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.